These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10563831)

  • 1. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay.
    Lever SZ; Parsons TL
    Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
    Zhu X; Lever SZ
    Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
    Aposhian HV; Aposhian MM
    Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
    Maiorino RM; Aposhian HV
    Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead chelates of meso- and racemic-dimercaptosuccinic acid.
    Rivera M; Aposhian HV; Fernando Q
    J Inorg Biochem; 1989 Dec; 37(4):283-93. PubMed ID: 2560792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine.
    Maiorino RM; Barry TJ; Aposhian HV
    Anal Biochem; 1987 Jan; 160(1):217-26. PubMed ID: 3032019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
    Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
    J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
    Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
    Aposhian HV; Maiorino RM; Dart RC; Perry DF
    Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
    Maiorino RM; Bruce DC; Aposhian HV
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 2,3-dimercaptosuccinic acid in mice blood and tissues by HPLC with fluorescence detection.
    Ju XH; Shi Y; Liu N; Guo RC; Wang BJ; Cui X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1621-6. PubMed ID: 19394283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
    Rivera M; Zheng W; Aposhian HV; Fernando Q
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning.
    Fang X; Fernando Q
    Chem Res Toxicol; 1995 Jun; 8(4):525-36. PubMed ID: 7548732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
    Haust HL; Inwood M; Spence JD; Poon HC; Peter F
    Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
    Fang X; Hua F; Fernando Q
    Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II).
    Rivera M; Levine DJ; Aposhian HV; Fernando Q
    Chem Res Toxicol; 1991; 4(1):107-14. PubMed ID: 1655086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.